Global Microbiome Drugs Market Insights and Forecast to 2028

Report ID: 1242984 | Published Date: Jan 2025 | No. of Page: 119 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Microbiome Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Oral Dosage Form
        1.2.3 Enteric Capsules
    1.3 Market by Symptom
        1.3.1 Global Microbiome Drugs Market Size Growth Rate by Symptom, 2017 VS 2021 VS 2028
        1.3.2 Gastrointestinal Disorders
        1.3.3 Autoimmune Disorders
        1.3.4 Diabetes
        1.3.5 Cancer
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Microbiome Drugs Market Perspective (2017-2028)
    2.2 Microbiome Drugs Growth Trends by Region
        2.2.1 Microbiome Drugs Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Microbiome Drugs Historic Market Size by Region (2017-2022)
        2.2.3 Microbiome Drugs Forecasted Market Size by Region (2023-2028)
    2.3 Microbiome Drugs Market Dynamics
        2.3.1 Microbiome Drugs Industry Trends
        2.3.2 Microbiome Drugs Market Drivers
        2.3.3 Microbiome Drugs Market Challenges
        2.3.4 Microbiome Drugs Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Microbiome Drugs Players by Revenue
        3.1.1 Global Top Microbiome Drugs Players by Revenue (2017-2022)
        3.1.2 Global Microbiome Drugs Revenue Market Share by Players (2017-2022)
    3.2 Global Microbiome Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Microbiome Drugs Revenue
    3.4 Global Microbiome Drugs Market Concentration Ratio
        3.4.1 Global Microbiome Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Microbiome Drugs Revenue in 2021
    3.5 Microbiome Drugs Key Players Head office and Area Served
    3.6 Key Players Microbiome Drugs Product Solution and Service
    3.7 Date of Enter into Microbiome Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Microbiome Drugs Breakdown Data by Type
    4.1 Global Microbiome Drugs Historic Market Size by Type (2017-2022)
    4.2 Global Microbiome Drugs Forecasted Market Size by Type (2023-2028)
5 Microbiome Drugs Breakdown Data by Symptom
    5.1 Global Microbiome Drugs Historic Market Size by Symptom (2017-2022)
    5.2 Global Microbiome Drugs Forecasted Market Size by Symptom (2023-2028)
6 North America
    6.1 North America Microbiome Drugs Market Size (2017-2028)
    6.2 North America Microbiome Drugs Market Size by Type
        6.2.1 North America Microbiome Drugs Market Size by Type (2017-2022)
        6.2.2 North America Microbiome Drugs Market Size by Type (2023-2028)
        6.2.3 North America Microbiome Drugs Market Share by Type (2017-2028)
    6.3 North America Microbiome Drugs Market Size by Symptom
        6.3.1 North America Microbiome Drugs Market Size by Symptom (2017-2022)
        6.3.2 North America Microbiome Drugs Market Size by Symptom (2023-2028)
        6.3.3 North America Microbiome Drugs Market Share by Symptom (2017-2028)
    6.4 North America Microbiome Drugs Market Size by Country
        6.4.1 North America Microbiome Drugs Market Size by Country (2017-2022)
        6.4.2 North America Microbiome Drugs Market Size by Country (2023-2028)
        6.4.3 United States
        6.4.4 Canada
7 Europe
    7.1 Europe Microbiome Drugs Market Size (2017-2028)
    7.2 Europe Microbiome Drugs Market Size by Type
        7.2.1 Europe Microbiome Drugs Market Size by Type (2017-2022)
        7.2.2 Europe Microbiome Drugs Market Size by Type (2023-2028)
        7.2.3 Europe Microbiome Drugs Market Share by Type (2017-2028)
    7.3 Europe Microbiome Drugs Market Size by Symptom
        7.3.1 Europe Microbiome Drugs Market Size by Symptom (2017-2022)
        7.3.2 Europe Microbiome Drugs Market Size by Symptom (2023-2028)
        7.3.3 Europe Microbiome Drugs Market Share by Symptom (2017-2028)
    7.4 Europe Microbiome Drugs Market Size by Country
        7.4.1 Europe Microbiome Drugs Market Size by Country (2017-2022)
        7.4.2 Europe Microbiome Drugs Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Microbiome Drugs Market Size (2017-2028)
    8.2 Asia-Pacific Microbiome Drugs Market Size by Type
        8.2.1 Asia-Pacific Microbiome Drugs Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Microbiome Drugs Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Microbiome Drugs Market Share by Type (2017-2028)
    8.3 Asia-Pacific Microbiome Drugs Market Size by Symptom
        8.3.1 Asia-Pacific Microbiome Drugs Market Size by Symptom (2017-2022)
        8.3.2 Asia-Pacific Microbiome Drugs Market Size by Symptom (2023-2028)
        8.3.3 Asia-Pacific Microbiome Drugs Market Share by Symptom (2017-2028)
    8.4 Asia-Pacific Microbiome Drugs Market Size by Region
        8.4.1 Asia-Pacific Microbiome Drugs Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Microbiome Drugs Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Microbiome Drugs Market Size (2017-2028)
    9.2 Latin America Microbiome Drugs Market Size by Type
        9.2.1 Latin America Microbiome Drugs Market Size by Type (2017-2022)
        9.2.2 Latin America Microbiome Drugs Market Size by Type (2023-2028)
        9.2.3 Latin America Microbiome Drugs Market Share by Type (2017-2028)
    9.3 Latin America Microbiome Drugs Market Size by Symptom
        9.3.1 Latin America Microbiome Drugs Market Size by Symptom (2017-2022)
        9.3.2 Latin America Microbiome Drugs Market Size by Symptom (2023-2028)
        9.3.3 Latin America Microbiome Drugs Market Share by Symptom (2017-2028)
    9.4 Latin America Microbiome Drugs Market Size by Country
        9.4.1 Latin America Microbiome Drugs Market Size by Country (2017-2022)
        9.4.2 Latin America Microbiome Drugs Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Microbiome Drugs Market Size (2017-2028)
    10.2 Middle East & Africa Microbiome Drugs Market Size by Type
        10.2.1 Middle East & Africa Microbiome Drugs Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Microbiome Drugs Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Microbiome Drugs Market Share by Type (2017-2028)
    10.3 Middle East & Africa Microbiome Drugs Market Size by Symptom
        10.3.1 Middle East & Africa Microbiome Drugs Market Size by Symptom (2017-2022)
        10.3.2 Middle East & Africa Microbiome Drugs Market Size by Symptom (2023-2028)
        10.3.3 Middle East & Africa Microbiome Drugs Market Share by Symptom (2017-2028)
    10.4 Middle East & Africa Microbiome Drugs Market Size by Country
        10.4.1 Middle East & Africa Microbiome Drugs Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Microbiome Drugs Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Seres Therapeutics
        11.1.1 Seres Therapeutics Company Details
        11.1.2 Seres Therapeutics Business Overview
        11.1.3 Seres Therapeutics Microbiome Drugs Introduction
        11.1.4 Seres Therapeutics Revenue in Microbiome Drugs Business (2017-2022)
        11.1.5 Seres Therapeutics Recent Developments
    11.2 Assembly Biosciences
        11.2.1 Assembly Biosciences Company Details
        11.2.2 Assembly Biosciences Business Overview
        11.2.3 Assembly Biosciences Microbiome Drugs Introduction
        11.2.4 Assembly Biosciences Revenue in Microbiome Drugs Business (2017-2022)
        11.2.5 Assembly Biosciences Recent Developments
    11.3 Synthetic Biologics
        11.3.1 Synthetic Biologics Company Details
        11.3.2 Synthetic Biologics Business Overview
        11.3.3 Synthetic Biologics Microbiome Drugs Introduction
        11.3.4 Synthetic Biologics Revenue in Microbiome Drugs Business (2017-2022)
        11.3.5 Synthetic Biologics Recent Developments
    11.4 Interxon
        11.4.1 Interxon Company Details
        11.4.2 Interxon Business Overview
        11.4.3 Interxon Microbiome Drugs Introduction
        11.4.4 Interxon Revenue in Microbiome Drugs Business (2017-2022)
        11.4.5 Interxon Recent Developments
    11.5 PureTech
        11.5.1 PureTech Company Details
        11.5.2 PureTech Business Overview
        11.5.3 PureTech Microbiome Drugs Introduction
        11.5.4 PureTech Revenue in Microbiome Drugs Business (2017-2022)
        11.5.5 PureTech Recent Developments
    11.6 Synlogic
        11.6.1 Synlogic Company Details
        11.6.2 Synlogic Business Overview
        11.6.3 Synlogic Microbiome Drugs Introduction
        11.6.4 Synlogic Revenue in Microbiome Drugs Business (2017-2022)
        11.6.5 Synlogic Recent Developments
    11.7 Enterome BioScience
        11.7.1 Enterome BioScience Company Details
        11.7.2 Enterome BioScience Business Overview
        11.7.3 Enterome BioScience Microbiome Drugs Introduction
        11.7.4 Enterome BioScience Revenue in Microbiome Drugs Business (2017-2022)
        11.7.5 Enterome BioScience Recent Developments
    11.8 4D Pharma
        11.8.1 4D Pharma Company Details
        11.8.2 4D Pharma Business Overview
        11.8.3 4D Pharma Microbiome Drugs Introduction
        11.8.4 4D Pharma Revenue in Microbiome Drugs Business (2017-2022)
        11.8.5 4D Pharma Recent Developments
    11.9 Second Genome
        11.9.1 Second Genome Company Details
        11.9.2 Second Genome Business Overview
        11.9.3 Second Genome Microbiome Drugs Introduction
        11.9.4 Second Genome Revenue in Microbiome Drugs Business (2017-2022)
        11.9.5 Second Genome Recent Developments
    11.10 AOBiome
        11.10.1 AOBiome Company Details
        11.10.2 AOBiome Business Overview
        11.10.3 AOBiome Microbiome Drugs Introduction
        11.10.4 AOBiome Revenue in Microbiome Drugs Business (2017-2022)
        11.10.5 AOBiome Recent Developments
    11.11 Rebiotix
        11.11.1 Rebiotix Company Details
        11.11.2 Rebiotix Business Overview
        11.11.3 Rebiotix Microbiome Drugs Introduction
        11.11.4 Rebiotix Revenue in Microbiome Drugs Business (2017-2022)
        11.11.5 Rebiotix Recent Developments
    11.12 Metabiomics
        11.12.1 Metabiomics Company Details
        11.12.2 Metabiomics Business Overview
        11.12.3 Metabiomics Microbiome Drugs Introduction
        11.12.4 Metabiomics Revenue in Microbiome Drugs Business (2017-2022)
        11.12.5 Metabiomics Recent Developments
    11.13 Ritter Pharmaceuticals
        11.13.1 Ritter Pharmaceuticals Company Details
        11.13.2 Ritter Pharmaceuticals Business Overview
        11.13.3 Ritter Pharmaceuticals Microbiome Drugs Introduction
        11.13.4 Ritter Pharmaceuticals Revenue in Microbiome Drugs Business (2017-2022)
        11.13.5 Ritter Pharmaceuticals Recent Developments
    11.14 Symberix
        11.14.1 Symberix Company Details
        11.14.2 Symberix Business Overview
        11.14.3 Symberix Microbiome Drugs Introduction
        11.14.4 Symberix Revenue in Microbiome Drugs Business (2017-2022)
        11.14.5 Symberix Recent Developments
    11.15 OpenBiome
        11.15.1 OpenBiome Company Details
        11.15.2 OpenBiome Business Overview
        11.15.3 OpenBiome Microbiome Drugs Introduction
        11.15.4 OpenBiome Revenue in Microbiome Drugs Business (2017-2022)
        11.15.5 OpenBiome Recent Developments
    11.16 Azitra
        11.16.1 Azitra Company Details
        11.16.2 Azitra Business Overview
        11.16.3 Azitra Microbiome Drugs Introduction
        11.16.4 Azitra Revenue in Microbiome Drugs Business (2017-2022)
        11.16.5 Azitra Recent Developments
    11.17 Osel
        11.17.1 Osel Company Details
        11.17.2 Osel Business Overview
        11.17.3 Osel Microbiome Drugs Introduction
        11.17.4 Osel Revenue in Microbiome Drugs Business (2017-2022)
        11.17.5 Osel Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
List of Tables
    Table 1. Global Microbiome Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Oral Dosage Form
    Table 3. Key Players of Enteric Capsules
    Table 4. Global Microbiome Drugs Market Size Growth Rate by Symptom (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Microbiome Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Microbiome Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Microbiome Drugs Market Share by Region (2017-2022)
    Table 8. Global Microbiome Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Microbiome Drugs Market Share by Region (2023-2028)
    Table 10. Microbiome Drugs Market Trends
    Table 11. Microbiome Drugs Market Drivers
    Table 12. Microbiome Drugs Market Challenges
    Table 13. Microbiome Drugs Market Restraints
    Table 14. Global Microbiome Drugs Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Microbiome Drugs Revenue Share by Players (2017-2022)
    Table 16. Global Top Microbiome Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microbiome Drugs as of 2021)
    Table 17. Ranking of Global Top Microbiome Drugs Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Microbiome Drugs Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Microbiome Drugs Product Solution and Service
    Table 21. Date of Enter into Microbiome Drugs Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Microbiome Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Microbiome Drugs Revenue Market Share by Type (2017-2022)
    Table 25. Global Microbiome Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Microbiome Drugs Revenue Market Share by Type (2023-2028)
    Table 27. Global Microbiome Drugs Market Size by Symptom (2017-2022) & (US$ Million)
    Table 28. Global Microbiome Drugs Revenue Share by Symptom (2017-2022)
    Table 29. Global Microbiome Drugs Forecasted Market Size by Symptom (2023-2028) & (US$ Million)
    Table 30. Global Microbiome Drugs Revenue Share by Symptom (2023-2028)
    Table 31. North America Microbiome Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Microbiome Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Microbiome Drugs Market Size by Symptom (2017-2022) & (US$ Million)
    Table 34. North America Microbiome Drugs Market Size by Symptom (2023-2028) & (US$ Million)
    Table 35. North America Microbiome Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Microbiome Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Microbiome Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Microbiome Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Microbiome Drugs Market Size by Symptom (2017-2022) & (US$ Million)
    Table 40. Europe Microbiome Drugs Market Size by Symptom (2023-2028) & (US$ Million)
    Table 41. Europe Microbiome Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Microbiome Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Microbiome Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Microbiome Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Microbiome Drugs Market Size by Symptom (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Microbiome Drugs Market Size by Symptom (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Microbiome Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Microbiome Drugs Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Microbiome Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Microbiome Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Microbiome Drugs Market Size by Symptom (2017-2022) & (US$ Million)
    Table 52. Latin America Microbiome Drugs Market Size by Symptom (2023-2028) & (US$ Million)
    Table 53. Latin America Microbiome Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Microbiome Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Microbiome Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Microbiome Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Microbiome Drugs Market Size by Symptom (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Microbiome Drugs Market Size by Symptom (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Microbiome Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Microbiome Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Seres Therapeutics Company Details
    Table 62. Seres Therapeutics Business Overview
    Table 63. Seres Therapeutics Microbiome Drugs Product
    Table 64. Seres Therapeutics Revenue in Microbiome Drugs Business (2017-2022) & (US$ Million)
    Table 65. Seres Therapeutics Recent Developments
    Table 66. Assembly Biosciences Company Details
    Table 67. Assembly Biosciences Business Overview
    Table 68. Assembly Biosciences Microbiome Drugs Product
    Table 69. Assembly Biosciences Revenue in Microbiome Drugs Business (2017-2022) & (US$ Million)
    Table 70. Assembly Biosciences Recent Developments
    Table 71. Synthetic Biologics Company Details
    Table 72. Synthetic Biologics Business Overview
    Table 73. Synthetic Biologics Microbiome Drugs Product
    Table 74. Synthetic Biologics Revenue in Microbiome Drugs Business (2017-2022) & (US$ Million)
    Table 75. Synthetic Biologics Recent Developments
    Table 76. Interxon Company Details
    Table 77. Interxon Business Overview
    Table 78. Interxon Microbiome Drugs Product
    Table 79. Interxon Revenue in Microbiome Drugs Business (2017-2022) & (US$ Million)
    Table 80. Interxon Recent Developments
    Table 81. PureTech Company Details
    Table 82. PureTech Business Overview
    Table 83. PureTech Microbiome Drugs Product
    Table 84. PureTech Revenue in Microbiome Drugs Business (2017-2022) & (US$ Million)
    Table 85. PureTech Recent Developments
    Table 86. Synlogic Company Details
    Table 87. Synlogic Business Overview
    Table 88. Synlogic Microbiome Drugs Product
    Table 89. Synlogic Revenue in Microbiome Drugs Business (2017-2022) & (US$ Million)
    Table 90. Synlogic Recent Developments
    Table 91. Enterome BioScience Company Details
    Table 92. Enterome BioScience Business Overview
    Table 93. Enterome BioScience Microbiome Drugs Product
    Table 94. Enterome BioScience Revenue in Microbiome Drugs Business (2017-2022) & (US$ Million)
    Table 95. Enterome BioScience Recent Developments
    Table 96. 4D Pharma Company Details
    Table 97. 4D Pharma Business Overview
    Table 98. 4D Pharma Microbiome Drugs Product
    Table 99. 4D Pharma Revenue in Microbiome Drugs Business (2017-2022) & (US$ Million)
    Table 100. 4D Pharma Recent Developments
    Table 101. Second Genome Company Details
    Table 102. Second Genome Business Overview
    Table 103. Second Genome Microbiome Drugs Product
    Table 104. Second Genome Revenue in Microbiome Drugs Business (2017-2022) & (US$ Million)
    Table 105. Second Genome Recent Developments
    Table 106. AOBiome Company Details
    Table 107. AOBiome Business Overview
    Table 108. AOBiome Microbiome Drugs Product
    Table 109. AOBiome Revenue in Microbiome Drugs Business (2017-2022) & (US$ Million)
    Table 110. AOBiome Recent Developments
    Table 111. Rebiotix Company Details
    Table 112. Rebiotix Business Overview
    Table 113. Rebiotix Microbiome Drugs Product
    Table 114. Rebiotix Revenue in Microbiome Drugs Business (2017-2022) & (US$ Million)
    Table 115. Rebiotix Recent Developments
    Table 116. Metabiomics Company Details
    Table 117. Metabiomics Business Overview
    Table 118. Metabiomics Microbiome Drugs Product
    Table 119. Metabiomics Revenue in Microbiome Drugs Business (2017-2022) & (US$ Million)
    Table 120. Metabiomics Recent Developments
    Table 121. Ritter Pharmaceuticals Company Details
    Table 122. Ritter Pharmaceuticals Business Overview
    Table 123. Ritter Pharmaceuticals Microbiome Drugs Product
    Table 124. Ritter Pharmaceuticals Revenue in Microbiome Drugs Business (2017-2022) & (US$ Million)
    Table 125. Ritter Pharmaceuticals Recent Developments
    Table 126. Symberix Company Details
    Table 127. Symberix Business Overview
    Table 128. Symberix Microbiome Drugs Product
    Table 129. Symberix Revenue in Microbiome Drugs Business (2017-2022) & (US$ Million)
    Table 130. Symberix Recent Developments
    Table 131. OpenBiome Company Details
    Table 132. OpenBiome Business Overview
    Table 133. OpenBiome Microbiome Drugs Product
    Table 134. OpenBiome Revenue in Microbiome Drugs Business (2017-2022) & (US$ Million)
    Table 135. OpenBiome Recent Developments
    Table 136. Azitra Company Details
    Table 137. Azitra Business Overview
    Table 138. Azitra Microbiome Drugs Product
    Table 139. Azitra Revenue in Microbiome Drugs Business (2017-2022) & (US$ Million)
    Table 140. Azitra Recent Developments
    Table 141. Osel Company Details
    Table 142. Osel Business Overview
    Table 143. Osel Microbiome Drugs Product
    Table 144. Osel Revenue in Microbiome Drugs Business (2017-2022) & (US$ Million)
    Table 145. Osel Recent Developments
    Table 146. Research Programs/Design for This Report
    Table 147. Key Data Information from Secondary Sources
    Table 148. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Microbiome Drugs Market Share by Type: 2021 VS 2028
    Figure 2. Oral Dosage Form Features
    Figure 3. Enteric Capsules Features
    Figure 4. Global Microbiome Drugs Market Share by Symptom: 2021 VS 2028
    Figure 5. Gastrointestinal Disorders Case Studies
    Figure 6. Autoimmune Disorders Case Studies
    Figure 7. Diabetes Case Studies
    Figure 8. Cancer Case Studies
    Figure 9. Others Case Studies
    Figure 10. Microbiome Drugs Report Years Considered
    Figure 11. Global Microbiome Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Microbiome Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Microbiome Drugs Market Share by Region: 2021 VS 2028
    Figure 14. Global Microbiome Drugs Market Share by Players in 2021
    Figure 15. Global Top Microbiome Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microbiome Drugs as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Microbiome Drugs Revenue in 2021
    Figure 17. North America Microbiome Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 18. North America Microbiome Drugs Market Size Market Share by Type (2017-2028)
    Figure 19. North America Microbiome Drugs Market Size Market Share by Symptom (2017-2028)
    Figure 20. North America Microbiome Drugs Market Size Share by Country (2017-2028)
    Figure 21. United States Microbiome Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Microbiome Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Microbiome Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 24. Europe Microbiome Drugs Market Size Market Share by Type (2017-2028)
    Figure 25. Europe Microbiome Drugs Market Size Market Share by Symptom (2017-2028)
    Figure 26. Europe Microbiome Drugs Market Size Share by Country (2017-2028)
    Figure 27. Germany Microbiome Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. France Microbiome Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. U.K. Microbiome Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Italy Microbiome Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Russia Microbiome Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Nordic Countries Microbiome Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Microbiome Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 34. Asia Pacific Microbiome Drugs Market Size Market Share by Type (2017-2028)
    Figure 35. Asia Pacific Microbiome Drugs Market Size Market Share by Symptom (2017-2028)
    Figure 36. Asia Pacific Microbiome Drugs Market Size Share by Region (2017-2028)
    Figure 37. China Microbiome Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Japan Microbiome Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. South Korea Microbiome Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Southeast Asia Microbiome Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. India Microbiome Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Australia Microbiome Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Latin America Microbiome Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 44. Latin America Microbiome Drugs Market Size Market Share by Type (2017-2028)
    Figure 45. Latin America Microbiome Drugs Market Size Market Share by Symptom (2017-2028)
    Figure 46. Latin America Microbiome Drugs Market Size Share by Country (2017-2028)
    Figure 47. Mexico Microbiome Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Brazil Microbiome Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Microbiome Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 50. Middle East and Africa Microbiome Drugs Market Size Market Share by Type (2017-2028)
    Figure 51. Middle East and Africa Microbiome Drugs Market Size Market Share by Symptom (2017-2028)
    Figure 52. Middle East and Africa Microbiome Drugs Market Size Share by Country (2017-2028)
    Figure 53. Turkey Microbiome Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Microbiome Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. UAE Microbiome Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Seres Therapeutics Revenue Growth Rate in Microbiome Drugs Business (2017-2022)
    Figure 57. Assembly Biosciences Revenue Growth Rate in Microbiome Drugs Business (2017-2022)
    Figure 58. Synthetic Biologics Revenue Growth Rate in Microbiome Drugs Business (2017-2022)
    Figure 59. Interxon Revenue Growth Rate in Microbiome Drugs Business (2017-2022)
    Figure 60. PureTech Revenue Growth Rate in Microbiome Drugs Business (2017-2022)
    Figure 61. Synlogic Revenue Growth Rate in Microbiome Drugs Business (2017-2022)
    Figure 62. Enterome BioScience Revenue Growth Rate in Microbiome Drugs Business (2017-2022)
    Figure 63. 4D Pharma Revenue Growth Rate in Microbiome Drugs Business (2017-2022)
    Figure 64. Second Genome Revenue Growth Rate in Microbiome Drugs Business (2017-2022)
    Figure 65. AOBiome Revenue Growth Rate in Microbiome Drugs Business (2017-2022)
    Figure 66. Rebiotix Revenue Growth Rate in Microbiome Drugs Business (2017-2022)
    Figure 67. Metabiomics Revenue Growth Rate in Microbiome Drugs Business (2017-2022)
    Figure 68. Ritter Pharmaceuticals Revenue Growth Rate in Microbiome Drugs Business (2017-2022)
    Figure 69. Symberix Revenue Growth Rate in Microbiome Drugs Business (2017-2022)
    Figure 70. OpenBiome Revenue Growth Rate in Microbiome Drugs Business (2017-2022)
    Figure 71. Azitra Revenue Growth Rate in Microbiome Drugs Business (2017-2022)
    Figure 72. Osel Revenue Growth Rate in Microbiome Drugs Business (2017-2022)
    Figure 73. Bottom-up and Top-down Approaches for This Report
    Figure 74. Data Triangulation
    Figure 75. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Seres Therapeutics
Assembly Biosciences
Synthetic Biologics
Interxon
PureTech
Synlogic
Enterome BioScience
4D Pharma
Second Genome
AOBiome
Rebiotix
Metabiomics
Ritter Pharmaceuticals
Symberix
OpenBiome
Azitra
Osel
Frequently Asked Questions
Microbiome Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Microbiome Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Microbiome Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Sterile Sample Bags

Sterile Sample Bags market is segmented by Specification and by Application. Players, stakeholder ... Read More

Roofing Underlayment

Roofing Underlayment market is segmented by Type and by Application. Players, stakeholders, and o ... Read More

Peelable Coating

Peelable Coating market is segmented by Type and by Application. Players, stakeholders, and other ... Read More